Q2 2025 13F Holders as of 6/30/2025
-
Type / Class
-
Equity / Common Stock
-
Number of holders
-
23
-
Total 13F shares, excl. options
-
2.26M
-
Shares change
-
-656K
-
Total reported value, excl. options
-
$4.68M
-
Value change
-
-$1.04M
-
Number of buys
-
10
-
Number of sells
-
-8
-
Price
-
$2.07
Significant Holders of Immix Biopharma, Inc. - Common Stock (IMMX) as of Q2 2025
27 filings reported holding IMMX - Immix Biopharma, Inc. - Common Stock as of Q2 2025.
Immix Biopharma, Inc. - Common Stock (IMMX) has 23 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 2.26M shares
.
Largest 10 shareholders include Bleichroeder LP (850K shares), VANGUARD GROUP INC (699K shares), GEODE CAPITAL MANAGEMENT, LLC (161K shares), MORGAN STANLEY (125K shares), NORTHERN TRUST CORP (93.9K shares), SUSQUEHANNA INTERNATIONAL GROUP, LLP (50.8K shares), STATE STREET CORP (43K shares), BlackRock, Inc. (40.3K shares), Private Advisor Group, LLC (31.2K shares), and TOCQUEVILLE ASSET MANAGEMENT L.P. (29.3K shares).
This table shows the top 23 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.